Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (8616)	6/5/2003 12:51:40 PM
From: Biomaven	Read Replies (2) \| Respond to of 52153

The biotechs are unreal today - this is my best day in ages, with the broader markets basically flat. I wonder if that CELG convertible deal was a turning point for biotechs - if almost free money is here (thank you deflationary expectations), then biotech certainly can find a use for it. Hard to know what to do here. I've compromised by selling some of my lower-quality stocks that have had substantial run-ups (stuff like LYNX and RNAI), as well as taking a little bit off the table on some of my bigger holdings. But sitting in cash isn't exactly appealing either, and I still don't like the broader market that much. Luxury hotels in Hong Kong are probably going cheap... <g> Peter